Similar articles for PMID: 27116898

Year	Number of Results
1987	1
1998	1
1999	2
2000	2
2003	1
2004	2
2005	1
2006	2
2007	1
2008	1
2009	1
2010	1
2011	2
2012	5
2013	5
2014	10
2015	7
2016	12
2017	13
2018	3
2020	1
2021	4
2022	5
2023	2
2024	0

1

Emerging site-specific bioconjugation strategies for radioimmunotracer development.

Massa S, Xavier C, Muyldermans S, Devoogdt N. Massa S, et al. Expert Opin Drug Deliv. 2016 Aug;13(8):1149-63. doi: 10.1080/17425247.2016.1178235. Epub 2016 May 13. Expert Opin Drug Deliv. 2016. PMID: 27116898 Review.

2

Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.

Massa S, Xavier C, De Vos J, Caveliers V, Lahoutte T, Muyldermans S, Devoogdt N. Massa S, et al. Bioconjug Chem. 2014 May 21;25(5):979-88. doi: 10.1021/bc500111t. Epub 2014 May 9. Bioconjug Chem. 2014. PMID: 24815083

3

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.

De Vos J, Devoogdt N, Lahoutte T, Muyldermans S. De Vos J, et al. Expert Opin Biol Ther. 2013 Aug;13(8):1149-60. doi: 10.1517/14712598.2013.800478. Epub 2013 May 16. Expert Opin Biol Ther. 2013. PMID: 23675652 Review.

4

Improving the targeting of therapeutics with single-domain antibodies.

Turner KB, Alves NJ, Medintz IL, Walper SA. Turner KB, et al. Expert Opin Drug Deliv. 2016;13(4):561-70. doi: 10.1517/17425247.2016.1133583. Epub 2016 Jan 25. Expert Opin Drug Deliv. 2016. PMID: 26689649 Review.

5

Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.

Massa S, Vikani N, Betti C, Ballet S, Vanderhaegen S, Steyaert J, Descamps B, Vanhove C, Bunschoten A, van Leeuwen FW, Hernot S, Caveliers V, Lahoutte T, Muyldermans S, Xavier C, Devoogdt N. Massa S, et al. Contrast Media Mol Imaging. 2016 Sep;11(5):328-339. doi: 10.1002/cmmi.1696. Epub 2016 May 5. Contrast Media Mol Imaging. 2016. PMID: 27147480 Free article.

6

Application Progress of the Single Domain Antibody in Medicine.

Tang H, Gao Y, Han J. Tang H, et al. Int J Mol Sci. 2023 Feb 20;24(4):4176. doi: 10.3390/ijms24044176. Int J Mol Sci. 2023. PMID: 36835588 Free PMC article. Review.

7

Nanobodies as molecular imaging probes.

Barakat S, Berksöz M, Zahedimaram P, Piepoli S, Erman B. Barakat S, et al. Free Radic Biol Med. 2022 Mar;182:260-275. doi: 10.1016/j.freeradbiomed.2022.02.031. Epub 2022 Feb 28. Free Radic Biol Med. 2022. PMID: 35240292 Review.

8

Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.

Adumeau P, Sharma SK, Brent C, Zeglis BM. Adumeau P, et al. Mol Imaging Biol. 2016 Apr;18(2):153-65. doi: 10.1007/s11307-015-0920-y. Mol Imaging Biol. 2016. PMID: 26754791 Free PMC article. Review.

9

Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview.

Sharma R, Suman SK, Mukherjee A. Sharma R, et al. Curr Med Chem. 2022;29(38):5979-6005. doi: 10.2174/0929867329666220607160559. Curr Med Chem. 2022. PMID: 35674298 Review.

10

Nanobodies and Cancer: Current Status and New Perspectives.

Allegra A, Innao V, Gerace D, Vaddinelli D, Allegra AG, Musolino C. Allegra A, et al. Cancer Invest. 2018 Apr 21;36(4):221-237. doi: 10.1080/07357907.2018.1458858. Epub 2018 Apr 16. Cancer Invest. 2018. PMID: 29658806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year